Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...
Inari Medical’s top-line growth is primarily driven by its ClotTriever and FlowTriever products that target patients with venous thromboembolism (VTE) (with significant growth opportunities ...
It delivered a trailing four-quarter average earnings surprise of 24.77%. Inari Medical’s top-line growth is primarily driven by its ClotTriever and FlowTriever products that target patients with ...
Zacks.com on MSN23d
Reasons to Retain Inari Medical Stock in Your Portfolio for NowInari Medical, Inc. NARI is well-poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency on ...
Inc. and Integer Holdings Corporation Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the ...
Inari’s ClotTriever Thrombectomy System Gains Reimbursement Approval in Japan December 2, 2024—Inari Medical, Inc. announced that it has received national reimbursement approval from the Japanese ...
Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback